HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Rectal malignant melanoma diagnosed by N-isopropyl- p-123I-iodoamphetamine single photon emission computed tomography and 5-S-cysteinyl dopa: report of a case.

Abstract
Malignant melanoma in the anorectal region is a rare disease associated with a very poor prognosis. Taking a biopsy of malignant melanoma is generally contraindicated because of the high risk of inducing metastasis. Although clinical examination and imaging findings are important for the preoperative diagnosis, conventional imaging techniques sometimes fail to provide information from which an accurate diagnosis can be made. We recently treated an 84-year-old woman with rectal malignant melanoma, in whom magnetic resonance imaging showed atypical findings. On the other hand, N-isopropyl- p-(123)I-iodoamphetamine single photon emission computed tomography and 5- S-cysteinyl dopa in blood serum, as a tumor marker of malignant melanoma, proved very effective for establishing the preoperative diagnosis. Despite radical abdominoperineal resection, the patient died of multiple liver and lung metastases about 5 months after surgery.
AuthorsSusumu Sato, Tatsuya Aoki, Kiyoharu Umezu, Munetaka Mori, Mikiya Hayashi, Hitoshi Saito, Keiichi Kitamura, Akihiko Tsuchida, Yasuhisa Koyanagi, Tetsuya Yamagishi, Kimihiko Abe
JournalSurgery today (Surg Today) Vol. 33 Issue 6 Pg. 454-8 ( 2003) ISSN: 0941-1291 [Print] Japan
PMID12768373 (Publication Type: Case Reports, Journal Article)
Chemical References
  • 5-S-cysteinyl-3,4-dihydroxyphenylalanine
  • Biomarkers, Tumor
  • Radiopharmaceuticals
  • Dihydroxyphenylalanine
  • Iofetamine
Topics
  • Aged
  • Aged, 80 and over
  • Biomarkers, Tumor (blood)
  • Dihydroxyphenylalanine (analogs & derivatives, blood)
  • Female
  • Humans
  • Iofetamine
  • Melanoma (diagnostic imaging)
  • Radiopharmaceuticals
  • Rectal Neoplasms (diagnostic imaging)
  • Tomography, Emission-Computed, Single-Photon

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: